首页 | 本学科首页   官方微博 | 高级检索  
     

GII.3型诺如病毒GZ31597株变异情况及与受体组织血型抗原结合模式分析
引用本文:王婧,张会芳,靳淼,谢华萍,孔翔羽,冯微宏,李宇宁,胡贵方,何雅青,段招军. GII.3型诺如病毒GZ31597株变异情况及与受体组织血型抗原结合模式分析[J]. 病毒学报, 2019, 0(1): 37-44
作者姓名:王婧  张会芳  靳淼  谢华萍  孔翔羽  冯微宏  李宇宁  胡贵方  何雅青  段招军
作者单位:南方医科大学公共卫生学院流行病学系;兰州大学第一临床医学院;中国疾病预防控制中心病毒病预防控制所国家卫生健康委员会医学病毒和病毒病重点实验室;广州市疾病预防控制中心;无锡市疾病预防控制中心;深圳市疾病预防控制中心微生物检验科
基金项目:无锡市科技发展资金(项目号:CSE31N1611);题目:人群易感性对诺如病毒株流行趋势的影响;卫计委面上项目(项目号:MS201617);题目:人群易感性对诺如病毒株流行趋势的影响;国家科技重大专项(项目号:2017ZX10104001-003);题目:基于全基因组的病毒网络化监测和溯源技术体系研究;中美新发和再发传染病合作项目(项目号:No.4);题目:中国诺如病毒实验室监测网络(CaliciNet China)的建立~~
摘    要:诺如病毒(Noroviruses,NoVs)是引起非菌型胃肠炎暴发流行的主要病原体之一。为了解我国GII.3型NoVs毒株的变异以及受体结合模式,本研究对来自2015年一起中国广州NoVs胃肠炎暴发的GII.3型毒株GZ31597株进行聚合酶区和完整VP1区基因扩增、序列测定和序列分析,并表达VP1突出区蛋白(P蛋白),通过P蛋白与不同血型唾液样本的酶免疫分析法(EIA)测定实验确定其组织血型抗原(Histo-blood group antigens,HBGAs)结合模式。GZ31597株聚合酶和VP1基因系统进化分析表明,GZ31597株为GII.P12/GII.3-SubD基因型(聚合酶/衣壳区),该毒株较先前的GII.3毒株相比,在既是抗原表位又是HBGAs受体结合位点的氨基酸385残基发生了氨基酸转换。根据Western Blotting结果,证实P蛋白成功表达。唾液结合分析结果显示,该毒株P蛋白与A、B、AB、O型分泌型以及O型非分泌型唾液均可以结合,但结合值相对低。本研究表明该GII.P12/GII.3-SubD亚型的GII.3毒株在长期的流行过程中,通过氨基酸的转换,改变抗原性和受体结合活性,使GII.3型毒株在人群中继续流行。通过探索GII.3型NoVs在人群中长期广泛流行的原因,为GII.3型诺如病毒性胃肠炎的预防和控制提供重要依据。

关 键 词:诺如病毒(NoVs)  GII.3基因型  进化  组织血型抗原(HBGAs)  P蛋白

Analyses of Variation of Norovirus GII.3 strain GZ 31597 and Its Binding Profile with Human Histo-blood Group Antigens
WANG Jing,ZHANG Huifang,JIN Miao,XIE Huaping,KONG Xiangyu,FENG Weihong,LI Yuning,HU Guifang,HE Yaqing,DUAN Zhaojun. Analyses of Variation of Norovirus GII.3 strain GZ 31597 and Its Binding Profile with Human Histo-blood Group Antigens[J]. Chinese journal of virology, 2019, 0(1): 37-44
Authors:WANG Jing  ZHANG Huifang  JIN Miao  XIE Huaping  KONG Xiangyu  FENG Weihong  LI Yuning  HU Guifang  HE Yaqing  DUAN Zhaojun
Affiliation:(Department of Epidemiology,School oj Public Health Southern Medical University,Guangzhou 510515,China;The First Clinical Medical College of Lanzhou University,Lanzhou 730000,China;Natiomd Inslitute for Viral Disease Control and Prevention.Chinese Center Control and Prevention,NHC Key Laboratory of Medical Virology and Viral Diseases,Beijing 102206,China;Guangzhou Center for Disease Control and Prevention,Guangzhou 510440,China;Wuai Center for Disease Control and Prevention,Wuxi 214023,China;Shenzhen Center for Disease Control and Prevention,Shenzhen 518055,China)
Abstract:Norovirus(NoVs) is the main cause of viral gastroenteritis worldwide. To understand variation of the GII.3 strain and its binding profile with human histo-blood group antigens(HBGAs), the partial RNA-dependent RNA polymerase(RdRp) sequence and complete VP1 sequence of the GII.3 strain GZ31597 isolated from an outbreak by NoVs in Guangzhou, China, in 2015 were amplified, sequenced and analyzed. Meanwhile, the protruding(P) domain in VP1 was expressed. The HBGAs binding profile of P protein with a panel of saliva samples(from which the blood type had been identified previously) was determined by an enzyme immunoassay. Phlylogenetic analyses in RdRp and VP1 indicated that the GZ31597 strain was genotyped into GII.P12/GII.3-SubD(RdRp/Capsid). Compared with previous GII.P12/GII.3-SubD strains, there was a switch at the amino-acid residue 385, which has antigen epitope and HBGAs receptor binding sites. The result of saliva binding showed that P protein was bound positively to A, B, AB, O secretors and O non-secretor, but the binding value was relatively low. The present study suggested that the GII.P12/GII.3-SubD genotype had changed its antigenicity and receptor-binding profile by switching amino-acids sites in the long-term epidemic process to continue to resist in the human population and explored why the GII.3 strain could prevail for such a long time in the population, and provides an important scientific basis for the prevention and treatment of viral diarrhea caused by the GII.3 strain.
Keywords:Norovirus(NoVs)  GII.3 strain  Evolution  Histo-blood group antigens(HBGAs)  P protein
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号